Research Article
Preparation and Characterization of a Gastric Floating Dosage Form of Capecitabine
Table 3
Drug release and floating profiles of twelve formulations.
| | Formulation | Release % | Floating lag time (s) | Total floating time (h) |
| | F1 | 100 | 30 | 20 | | F2 | 83.665 | 70 | 24 | | F3 | 76.3 | 81 | 24 | | F4 | 100 | 35 | 20 | | F5 | 90.305 | 45 | 24 | | F6 | 84.711 | 60 | 24 | | F7 | 98.286 | 60 | 24 | | F8 | 83.665 | 70 | 24 | | F9 | 78.82 | 85 | 24 | | F10 | 86.666 | 60 | 24 | | F11 | 80.54 | 80 | 24 | | F12 | 75.226 | 200 | 0.5 |
|
|
s: second; hr: hour.
|
